INTRODUCTION:
Respiratory diseases remain a leading cause of morbidity and mortality among infants and young children worldwide. Lower respiratory tract infections disproportionately affect newborns and vulnerable paediatric populations, particularly in low- and middle-income countries, but also among underserved groups in high-income settings. Respiratory syncytial virus (RSV) is the leading cause of hospitalisation for acute lower respiratory infections in infants globally, while pneumococcal disease continues to impose a substantial burden through pneumonia, sepsis, and meningitis, despite the availability of effective vaccines. The availability of new preventive tools for RSV, together with long-standing evidence supporting pneumococcal vaccination, creates a timely opportunity to strengthen early-life prevention through coordinated, evidence-informed policy action.

METHODS:
Led by the World Federation of Public Health Associations (WFPHA), this initiative adopts a structured policy-dialogue approach. The session will present a Call to Action aimed at strengthening the prevention of respiratory diseases in infants, with a primary focus on RSV and pneumococcal vaccination. The Call to Action has been developed under the auspices of the WFPHA International Immunization Policy Taskforce. Policymakers, public health leaders, clinicians, researchers, and global health stakeholders will discuss the proposed Call to Action, identify feasible implementation approaches, and exchange regional experiences related to infant RSV and pneumococcal prevention. The discussion will be highly interactive, actively engaging participants to promote shared learning and practical problem-solving.

RESULTS:
Participants will identify priority actions to support national implementation, strengthen policy coherence, enhance delivery capacity, and promote equitable access to preventive interventions across diverse regional and health-system contexts.

CONCLUSIONS:
This initiative supports countries and global actors in advancing effective, equitable, and scalable prevention strategies for RSV and pneumococcal disease in infants and children. By translating policy dialogue into concrete action, it aims to inspire public health professionals to accelerate the transition from evidence to implementation in paediatric respiratory health.